Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
EyeSense AG is a pioneering Swiss medical technology company focused on developing and commercializing innovative solutions for ophthalmology, particularly in the field of glaucoma management. Their core technology centers around a proprietary, implantable, telemetric sensor for non-invasive, continuous intraocular pressure (IOP) monitoring. This aims to provide ophthalmologists and patients with significantly more data than traditional methods, enabling personalized treatment strategies and potentially improving outcomes for individuals at risk of or suffering from glaucoma. EyeSense is committed to advancing eye care through cutting-edge research, engineering, and clinical validation.
The Zurich headquarters serves as the primary center for research and development, product engineering, clinical trial management, strategic partnerships, and corporate operations.
Located within Technopark Zurich, providing access to a vibrant ecosystem of startups, research institutions (like ETH Zurich and University of Zurich nearby), and established technology companies, fostering collaboration and innovation.
The work culture at EyeSense AG's headquarters is likely dynamic, research-intensive, and collaborative, with a strong emphasis on scientific rigor, precision engineering, and a shared mission to improve patient lives. It encourages innovation and interdisciplinary teamwork.
The Zurich location is significant due to Switzerland's strong reputation in medical technology, access to highly skilled talent, a supportive regulatory environment for medical devices, and proximity to leading ophthalmic research centers.
While headquartered and conducting primary R&D in Switzerland, EyeSense AG aims for a global impact with its medical devices. Their global presence is currently focused on establishing clinical trial sites in multiple countries, engaging with international regulatory bodies (e.g., FDA, EMA), and forming strategic partnerships for future market access and distribution in key regions such as Europe, North America, and potentially Asia. They actively participate in international ophthalmology conferences to showcase their technology.
Technoparkstrasse 1
Zurich
Zurich
Switzerland
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, EyeSense' leadership includes:
EyeSense has been backed by several prominent investors over the years, including:
Based on publicly available information, EyeSense AG's core executive team appears to have remained stable over the last 12 months. No major high-profile executive hires or departures have been announced.
Discover the tools EyeSense uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
EyeSense AG likely utilizes common professional email formats. Based on standard practices for Swiss companies and technology firms, formats such as [first_initial][last]@[domain] or [first].[last]@[domain] are probable.
[first_initial][last]@eyesense.ch or [first].[last]@eyesense.ch
Format
pcattin@eyesense.ch or philippe.cattin@eyesense.ch
Example
80%
Success rate
startupticker.ch • November 17, 2023
EyeSense has developed the first telemetry-based sensor for continuous and non-invasive monitoring of intraocular pressure. Following successful tests, the medtech startup is on the cusp of its first in-human clinical study. An ongoing financing round will support the company achieve this milestone....more
venturelab.swiss • October 5, 2023
EyeSense AG was selected as one of the Venture Leaders Medtech 2023, recognizing it as one of Switzerland's most promising medtech startups. This involved participation in an international roadshow....more
Swiss Innovation Agency Innosuisse • June 23, 2022
EyeSense AG successfully closed a seed financing round, securing CHF 2.1 million. The funds are intended to advance the development of their intraocular pressure sensor and prepare for clinical trials....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including EyeSense, are just a search away.